Connor Clark & Lunn Investment Management Ltd. increased its position in Oracle Corporation (NYSE:ORCL – Free Report) by 207.4% in the second quarter, HoldingsChannel.com reports. The fund owned 216,889 shares of the enterprise software provider’s stock after buying an additional 146,323 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Oracle were worth $47,418,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ORCL. Brighton Jones LLC lifted its stake in Oracle by 189.3% during the 4th quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock valued at $25,593,000 after acquiring an additional 100,494 shares during the period. Revolve Wealth Partners LLC lifted its position in Oracle by 8.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock valued at $903,000 after purchasing an additional 404 shares during the period. Kesler Norman & Wride LLC boosted its holdings in Oracle by 3.2% in the first quarter. Kesler Norman & Wride LLC now owns 5,484 shares of the enterprise software provider’s stock valued at $767,000 after purchasing an additional 171 shares during the last quarter. Harmony Asset Management LLC grew its position in Oracle by 2.3% during the 1st quarter. Harmony Asset Management LLC now owns 22,077 shares of the enterprise software provider’s stock worth $3,087,000 after purchasing an additional 494 shares during the period. Finally, Riversedge Advisors LLC purchased a new position in shares of Oracle during the 1st quarter valued at about $202,000. Institutional investors and hedge funds own 42.44% of the company’s stock.
Analyst Ratings Changes
A number of analysts have recently commented on the company. Scotiabank upped their target price on Oracle from $350.00 to $360.00 and gave the stock an “outperform” rating in a research note on Friday, October 17th. BMO Capital Markets set a $355.00 price target on Oracle and gave the company an “outperform” rating in a report on Monday, October 13th. Piper Sandler raised their price objective on shares of Oracle from $330.00 to $380.00 and gave the stock an “overweight” rating in a research note on Friday, October 17th. JMP Securities reaffirmed a “market outperform” rating and set a $342.00 target price on shares of Oracle in a report on Friday, October 17th. Finally, The Goldman Sachs Group reiterated a “neutral” rating and issued a $320.00 target price on shares of Oracle in a research note on Monday, October 20th. Three analysts have rated the stock with a Strong Buy rating, twenty-six have given a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $323.69.
Insider Activity at Oracle
In other Oracle news, Director Jeffrey Berg sold 49,365 shares of the stock in a transaction that occurred on Tuesday, October 28th. The stock was sold at an average price of $283.02, for a total transaction of $13,971,282.30. Following the completion of the transaction, the director owned 151,999 shares of the company’s stock, valued at $43,018,756.98. This represents a 24.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Clayton M. Magouyrk sold 40,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of $276.64, for a total value of $11,065,600.00. Following the completion of the transaction, the chief executive officer owned 154,030 shares in the company, valued at approximately $42,610,859.20. This trade represents a 20.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 204,254 shares of company stock worth $60,227,807 in the last quarter. Corporate insiders own 40.90% of the company’s stock.
Oracle Trading Down 1.9%
Shares of NYSE:ORCL opened at $239.15 on Friday. The business’s 50 day moving average price is $279.32 and its 200-day moving average price is $230.60. Oracle Corporation has a 1 year low of $118.86 and a 1 year high of $345.72. The firm has a market capitalization of $681.77 billion, a price-to-earnings ratio of 55.36, a price-to-earnings-growth ratio of 2.96 and a beta of 1.51. The company has a debt-to-equity ratio of 3.33, a current ratio of 0.62 and a quick ratio of 0.62.
Oracle (NYSE:ORCL – Get Free Report) last posted its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). The company had revenue of $14.93 billion for the quarter, compared to analyst estimates of $15.04 billion. Oracle had a return on equity of 72.93% and a net margin of 21.08%.The business’s revenue was up 12.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.39 earnings per share. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, equities research analysts forecast that Oracle Corporation will post 5 earnings per share for the current fiscal year.
Oracle Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 23rd. Investors of record on Thursday, October 9th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.8%. The ex-dividend date was Thursday, October 9th. Oracle’s payout ratio is presently 46.30%.
About Oracle
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Articles
- Five stocks we like better than Oracle
- Compound Interest and Why It Matters When Investing
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- Canada Bond Market Holiday: How to Invest and Trade
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- Using the MarketBeat Dividend Tax Calculator
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
